Location History:
- Berlin, DE (2015 - 2020)
- Falkensee, DE (2021 - 2022)
- Falkenesee, DE (2023)
Company Filing History:
5 out of 12,164 
5 out of 444 
4 out of 378 
Years Active: 2015-2025
Title: Charlotte Christine Kopitz: Innovator in Pharmaceutical Compounds
Introduction
Charlotte Christine Kopitz is a notable inventor based in Falkensee, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of hyperproliferative diseases. With a total of five patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Among her latest patents, one includes the invention of 1,2,4-triazin-3(2H)-one compounds aimed at treating hyperproliferative diseases. This invention encompasses compounds of a general formula, along with methods for their preparation, pharmaceutical compositions, and their applications in medical treatments. Another significant patent involves dihydrooxadiazinones, which are compounds designed for the treatment or prophylaxis of diseases, particularly hyperproliferative diseases. This patent details methods of preparing these compounds, intermediate compounds useful for their synthesis, and their incorporation into pharmaceutical compositions.
Career Highlights
Charlotte has worked with prominent organizations such as Bayer Aktiengesellschaft and The Broad Institute, Inc. Her experience in these companies has allowed her to refine her expertise in pharmaceutical research and development.
Collaborations
Throughout her career, Charlotte has collaborated with notable colleagues, including Manuel Ellermann and Martin Lange. These partnerships have contributed to her innovative work and the advancement of her research.
Conclusion
Charlotte Christine Kopitz stands out as a pioneering inventor in the pharmaceutical industry. Her contributions to the development of compounds for treating serious diseases highlight her commitment to advancing medical science.